Aurinia Pharmaceuticals Inc.

AUPH ·Healthcare, Drug Manufacturers - General, Alberta, Canada
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016
Assets
Cash & Equivalents $165.6M $39.6M
Accounts Receivable — —
Inventory — —
Total Current Assets $175.3M $41.4M
Property, Plant & Equipment — —
Goodwill — —
Intangible Assets (Excl. Goodwill) — —
Total Assets $189.8M $57.0M
Liabilities
Accounts Payable $8.0M $5.8M
Total Current Liabilities $8.2M $7.9M
Long-Term Debt — —
Total Liabilities $11.9M $21.0M
Stockholders' Equity
Retained Earnings $-351.8M $-281.0M
Total Stockholders' Equity $177.9M $36.0M
← Newer Page 2 of 2 Older →